ArticleBlood advances2018
Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction.
Oliver Borst et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it